| Product Code: ETC9685819 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Glucocorticoid Agonist Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Glucocorticoid Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Glucocorticoid Agonist Market - Industry Life Cycle |
3.4 Thailand Glucocorticoid Agonist Market - Porter's Five Forces |
3.5 Thailand Glucocorticoid Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Thailand Glucocorticoid Agonist Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 Thailand Glucocorticoid Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Thailand Glucocorticoid Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Thailand Glucocorticoid Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Glucocorticoid Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune and inflammatory diseases in Thailand |
4.2.2 Growing awareness about the benefits of glucocorticoid agonists in managing various medical conditions |
4.2.3 Rise in healthcare expenditure and investments in healthcare infrastructure in Thailand |
4.3 Market Restraints |
4.3.1 Stringent government regulations and policies related to the usage of glucocorticoid agonists |
4.3.2 Potential side effects associated with long-term use of glucocorticoid agonists |
4.3.3 Competition from alternative treatment options and therapies in the market |
5 Thailand Glucocorticoid Agonist Market Trends |
6 Thailand Glucocorticoid Agonist Market, By Types |
6.1 Thailand Glucocorticoid Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Anti-inflammatory, 2021- 2031F |
6.1.4 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Eyes Disorders, 2021- 2031F |
6.1.5 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Glucocorticoid Agonist Market, By Products |
6.2.1 Overview and Analysis |
6.2.2 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Corticosterone, 2021- 2031F |
6.2.3 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Fluticasone Propionate, 2021- 2031F |
6.2.4 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Methylprednisolone, 2021- 2031F |
6.2.5 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Mometasone Furoate, 2021- 2031F |
6.2.6 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Glucocorticoid Agonist Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.5 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Ocular, 2021- 2031F |
6.3.6 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Glucocorticoid Agonist Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Glucocorticoid Agonist Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Thailand Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Glucocorticoid Agonist Market Import-Export Trade Statistics |
7.1 Thailand Glucocorticoid Agonist Market Export to Major Countries |
7.2 Thailand Glucocorticoid Agonist Market Imports from Major Countries |
8 Thailand Glucocorticoid Agonist Market Key Performance Indicators |
8.1 Prescription rate of glucocorticoid agonists by healthcare providers |
8.2 Patient adherence and compliance rates to glucocorticoid agonist treatment regimens |
8.3 Number of clinical trials and research studies focused on glucocorticoid agonists in Thailand |
9 Thailand Glucocorticoid Agonist Market - Opportunity Assessment |
9.1 Thailand Glucocorticoid Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Thailand Glucocorticoid Agonist Market Opportunity Assessment, By Products, 2021 & 2031F |
9.3 Thailand Glucocorticoid Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Thailand Glucocorticoid Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Thailand Glucocorticoid Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Glucocorticoid Agonist Market - Competitive Landscape |
10.1 Thailand Glucocorticoid Agonist Market Revenue Share, By Companies, 2024 |
10.2 Thailand Glucocorticoid Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here